Hinge Health demonstrates a robust and scalable business model with strong AI-driven differentiation in a large and expanding market. Its recurring revenue base, client growth, and margin expansion are supported by proprietary technology and an emerging provider network, creating sustainable compet…
Hinge Health (HNGE) Q3 2025: 53% Revenue Growth Accelerates AI-Driven Care Automation
Hinge Health’s third quarter performance underscores rapid adoption of its AI-powered musculoskeletal care platform, driving substantial operational leverage and record free cash flow. The company’s strategic investments in AI across product and engineering accelerate efficiency gains and client engagement, supporting a raised full-year revenue and profitability outlook. Market traction in large enterprise and federal segments, combined with early Hinge Select provider network rollout, positions Hinge for sustained growth in a healthcare cost containment environment.
Summary
- AI-Powered Care Transformation: Innovative AI tools enhance member engagement and operational efficiency.
- Commercial Momentum: Robust client growth and pipeline strength underpin expanding market footprint.
- Operational Leverage: Significant margin expansion and free cash flow generation highlight scalable business model.
Business Overview
Hinge Health is a technology-driven healthcare company focused on automating musculoskeletal (MSK) care delivery through an AI-powered platform that combines digital physical therapy, wearable devices, and expert clinical support. The company generates revenue primarily by contracting with employers and health plans, offering services that improve outcomes and reduce healthcare costs. Its major segments include digital MSK care and the emerging Hinge Select provider network, which integrates high-quality in-person care with its digital platform.
Performance Analysis
In Q3 2025, Hinge Health delivered $154.2 million in revenue, marking a 53% year-over-year increase, fueled by a 50% rise in last twelve months (LTM) calculated billings to $624 million. This growth was supported by a 25% increase in contracted clients to 2,560 and strong performance across the three billings drivers: eligible lives, yield, and stable average selling price (ASP). Targeted enrollment initiatives, leveraging the HingeConnect data platform, more than doubled member enrollments compared to the prior year, contributing significantly to yield improvements.
Operational efficiency improved markedly, with GAAP gross margin rising to 82% and non-GAAP gross margin to 83%, reflecting the scalability of AI-enabled care delivery. Operating expenses as a percentage of revenue declined to 63%, enabling a non-GAAP operating margin of 20%, a substantial improvement from negative 4% in Q3 2024. Free cash flow reached a record $81 million, representing a 53% margin, driven by improved collections and cost discipline. These results underscore the company’s ability to grow profitably while investing in innovation and market expansion.
- Billings Growth Drivers: Balanced growth across eligible lives, yield enhancements, and stable pricing underpin revenue acceleration.
- Margin Expansion: AI-powered care team efficiencies and operational leverage drive over 600 basis points improvement in operating margin.
- Cash Flow Strength: Record free cash flow generation highlights robust collections and disciplined capital management.
Overall, Hinge Health’s financial and operational performance demonstrates the effectiveness of its AI-centric strategy in scaling care delivery and capturing market share in a large and growing MSK healthcare segment.
Executive Commentary
"We delivered $154 million in revenue for Q3, representing 53% year-over-year growth. Our AI-powered platform is transforming care at scale, increasing engagement for our members and reducing healthcare costs for our clients."
Daniel Perez, Co-Founder & CEO
"Our LTM calculated billings reached $624 million, up 50% year over year. We generated $81 million in free cash flow, a free cash flow margin of 53%, highlighting the strength of our business model and operational efficiency."
James Budge, CFO
Strategic Positioning
1. AI-Driven Care Automation
Hinge Health’s AI care assistant, Robin, provides 24/7 personalized support, proactively addressing pain flare-ups and streamlining communication with clinicians. The company’s innovative movement analysis technology applies computer vision to deliver objective joint health metrics, enhancing clinical insights beyond subjective self-reports. These AI-enabled tools increase member engagement, improve outcomes, and reduce costs, reinforcing client retention and expanding enrollment yields.
2. Commercial Expansion and Client Base Growth
The company achieved a 25% increase in contracted clients, with strong traction among jumbo self-insured groups, federal employee programs, and fully insured segments. The standardized contracting process through health plan partnerships reduces negotiation complexity, accelerating sales cycles. Hinge Health’s year-over-year improvement in win rates and a growing pipeline position it well for continued market share gains.
3. Hinge Select Provider Network Development
Hinge Select integrates high-quality in-person care with the digital platform, creating a two-sided marketplace with over 3,300 contracted provider locations nationwide. Early client feedback is positive, and 86% of eligible lives reside within the network footprint. While initial costs are embedded in current forecasts, meaningful revenue contributions are expected starting in 2027, supporting a differentiated and comprehensive care offering.
4. Operational Efficiency and AI Adoption Across Organization
The engineering team doubled code output and accelerated feature deployment by 120% year-over-year, driven by near 100% AI adoption among developers. AI initiatives have contributed to approximately half of the 2600 basis points improvement in gross and operating margins. Care team headcount is expected to remain flat in 2026 despite revenue growth, reflecting productivity gains from automation.
5. Capital Allocation and Growth Investment Discipline
Strong free cash flow and cash reserves of nearly $497 million enable continued investment in organic growth, product innovation, and targeted M&A opportunities. Management emphasizes close control of stock-based compensation to manage dilution and aims for sustainable GAAP profitability while expanding market reach.
Key Considerations
Hinge Health’s Q3 results reflect a maturing business model that balances rapid growth with operational discipline and innovation.
- Seasonality and Sales Cycle: Majority of client contracts finalize in H2 with launches in Q1, creating predictable revenue rhythm and potential Q4 softness relative to Q3.
- Targeted Enrollment Initiatives: Continued investment in data integration and high-risk member identification drives yield improvements and client ROI.
- AI as a Competitive Moat: Ethical AI development principles and responsible deployment underpin client trust and differentiation in healthcare.
- Provider Network Scaling: Building a high-quality, cost-effective in-person network supports comprehensive care but requires upfront investment and operational sophistication.
- Federal Government Shutdown Impact: No material effect observed to date; federal health benefits remain funded through year-end, sustaining business momentum.
Risks
Potential risks include uncertainties related to AI adoption in healthcare due to privacy and regulatory concerns, the impact of federal government shutdown extension beyond 2025 year-end on client contracts, and execution challenges in scaling the Hinge Select network. Additionally, reliance on health plan partnerships for contracting may expose the company to negotiation or regulatory shifts affecting client acquisition.
Forward Outlook
For Q4 2025, Hinge Health projects revenue between $155 million and $157 million, reflecting 33% year-over-year growth at the midpoint, with non-GAAP income from operations of $34 million to $36 million and a 22% operating margin. Full-year 2025 guidance has been raised to $572 million to $574 million in revenue, a 47% increase, and $106 million to $108 million in non-GAAP income from operations, representing a 19% margin. Management highlighted sustained strength across lives, yield, and pricing, along with accelerating AI-driven operational efficiencies as key drivers.
Takeaways
Hinge Health’s Q3 2025 results reveal a business executing effectively on its mission to automate musculoskeletal care through AI, delivering strong commercial momentum and operational leverage.
- Strong Growth and Efficiency: Balanced growth in clients, yield, and pricing combined with AI-powered automation drives exceptional margin expansion and cash flow generation.
- Product Innovation as Differentiator: AI initiatives such as Robin and movement analysis enhance member experience and clinical outcomes, supporting client retention and market leadership.
- Strategic Investments to Sustain Growth: Expansion of Hinge Select and disciplined capital allocation position the company for long-term competitive advantage and scalable growth.
Conclusion
Hinge Health’s Q3 performance confirms the scalability and profitability of its AI-enabled care delivery platform, supported by robust commercial traction and operational discipline. With a raised outlook and continued innovation, the company is well positioned to capitalize on the significant opportunity in automating musculoskeletal healthcare.
Industry Read-Through
Hinge Health’s integration of AI and digital care with a provider network exemplifies the evolving healthcare landscape where technology enhances both outcomes and cost management. Its success in embedding AI responsibly while driving operational efficiencies offers a blueprint for digital health companies targeting large, cost-sensitive markets. The strong demand from large employers and federal clients underscores the growing prioritization of musculoskeletal care as a key cost driver. Other healthcare technology providers should monitor Hinge’s approach to scaling AI-enabled services and two-sided marketplaces as a competitive benchmark.